McBroom & Associates’s Axon Enterprise AXON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.31M Sell
7,683
-433
-5% -$181K 2.17% 19
2026
Q1
$3.45M Buy
8,116
+367
+5% +$191K 1.92% 19
2025
Q4
$4.4M Buy
7,749
+365
+5% +$226K 2.14% 19
2025
Q3
$5.3M Buy
7,384
+4,195
+132% +$3.18M 2.52% 18
2025
Q2
$1.68M Hold
3,189
0.96% 25
2025
Q1
$1.68M Buy
+3,189
New +$1.87M 0.96% 25

Other funds holding AXON

McBroom & Associates's AXON Position: Q2 2026 in Review

McBroom & Associates reduced its Axon Enterprise (AXON) stake by 5.3% in Q2 2026, selling an estimated $181K and leaving 7,683 shares worth $4.31M. The position accounts for 2.17% of the portfolio, ranked #19.

McBroom & Associates first reported a position in AXON in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.3M in Q3 2025. 431 funds tracked by Wall St. Rank hold AXON as of Q2 2026.

  • McBroom & Associates held 7,683 shares of Axon Enterprise worth $4.31M as of Q2 2026.
  • McBroom & Associates sold 433 Axon Enterprise shares in Q2 2026, an estimated $181K.
  • Axon Enterprise made up 2.17% of McBroom & Associates's portfolio in Q2 2026, its #19 holding.
  • McBroom & Associates first reported a position in Axon Enterprise in Q1 2025 and has held it in 6 quarters since.
  • McBroom & Associates's Axon Enterprise position peaked at $5.3M in Q3 2025.
  • 431 funds tracked by Wall St. Rank held Axon Enterprise as of Q2 2026.

Based on McBroom & Associates's 13F filing for Q2 2026, filed 30 Jul 2026.